Начало・Списък с акции・Schrodinger Inc

Schrodinger Inc

Затворен

СекторЗдравеопазване

18.39 -1.34

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

18.17

Максимум

18.72

Ключови измерители
By Trading Economics
Приходи	66M 6M
Продажби	302K 59M
EPS	0.08
Марж на печалбата	10.146
Служители	850
EBITDA	65M 7.3M

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	+8.58% upside

Дивиденти
By Acuity
Следващи печалби	4.11.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	217M 1.4B
Предишно отваряне	19.73
Предишно затваряне	18.39

Настроения в новините

By Acuity

72%

28%

299 / 340 Класиране в Healthcare

Schrodinger Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

11.08.2026 г., 19:16 ч. UTC

Shares of Schrodinger Inc. are trading higher, maintaining a position above the 20-day moving average amid no specific company news.

10.08.2026 г., 19:36 ч. UTC

Schrodinger Inc's shares are higher today, continuing a six-day advance amid supportive market conditions and heightened geopolitical tensions affecting investor sentiment.

7.08.2026 г., 19:16 ч. UTC

Correlated Moves

Schrodinger Inc shares are higher today, supported by a broader market trend and gains in the Russell 2000 Index, despite some macroeconomic uncertainties.

6.08.2026 г., 23:01 ч. UTC

Schrodinger Inc shares declined in after-market trading, reversing gains from the previous four sessions. The stock remains above its 20-day moving average.

5.08.2026 г., 23:01 ч. UTC

News

Schrodinger Inc reported second-quarter adjusted EPS of $0.08, surpassing estimates. Revenue reached $58.889 million, leading to higher after-market trading.

3.08.2026 г., 19:51 ч. UTC

Correlated Moves

Schrodinger Inc shares are higher, reflecting broader market gains amid a drop in oil prices and positive sentiment in the technology sector.

31.07.2026 г., 19:46 ч. UTC

Correlated Moves

Schrodinger Inc shares are lower amid declining first-quarter results and broader market pressure, despite an earlier rebound from session lows.

30.07.2026 г., 18:46 ч. UTC

Correlated Moves

Schrodinger Inc. advanced during Thursday's session, supported by broader market gains despite earlier pulling back from a session high.

29.07.2026 г., 20:51 ч. UTC

Correlated Moves

Schrodinger Inc shares are lower in after-market trading, influenced by a broader market downturn and rising crude oil prices amid geopolitical tensions.

28.07.2026 г., 23:01 ч. UTC

Schrodinger Inc. shares declined in after-market trading, remaining below their 20-day moving average amid broader market strength and pressure on technology stocks.

27.07.2026 г., 22:51 ч. UTC

Schrodinger Inc. shares are higher in after-market trading, despite remaining below their 20-day moving average amid broader market dynamics and falling crude oil prices.

24.07.2026 г., 15:11 ч. UTC

Schrodinger Inc shares are declining today, continuing a downward trend since Thursday's close. A pullback in crude oil prices may be affecting investor sentiment.

20.07.2026 г., 15:12 ч. UTC

Correlated Moves

Schrodinger Inc. shares are lower amid a decline in the ARK Genomic Revolution ETF and broader market pressures, despite a slight rebound earlier in the session.

Сравнение с други в отрасъла

Ценова промяна

Schrodinger Inc Прогноза

Ценова цел

By TipRanks

8.58% нагоре

12-месечна прогноза

Среден 20.25 USD 8.58%

Висок 24 USD

Нисък 17 USD

Според 6 анализатори от Wall Street, предложили 12-месечна ценова цел за Schrodinger Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

6 ratings

Купи

Задържане

Продай

Според 6 анализатори, дали борсови рейтинги на Schrodinger Inc през последните 3 месеца.

Настроение

By Acuity

299 / 340 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Schrodinger Inc

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. It has a research collaboration and license agreement with Novartis AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.